Activest Wealth Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

Activest Wealth Management’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$8.1K	Hold	74	–	–	﹤0.01%	618
2026 Q2	$8.09K	Hold	74	–	–	﹤0.01%	623
2026 Q1	$7.69K	Hold	74	–	–	﹤0.01%	740
2025 Q4	$7.64K	Hold	74	–	–	﹤0.01%	711
2025 Q3	$6.69K	Hold	74	–	–	﹤0.01%	590
2025 Q2	$6.51K	Hold	74	–	–	﹤0.01%	511
2025 Q1	$6.74K	Sell	74 -299	-80%	-$26.9K	﹤0.01%	466
2024 Q4	$32.2K	Buy	+373	New	+$33.7K	0.01%	211
2023 Q1	–	Sell	-880	Closed	-$70.1K	–	495
2022 Q4	$70.1K	Buy	+880	New	+$64.9K	0.02%	163

Other funds holding PPH

J. Safra Asset Management New York $2.3B AUM 21.55% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Adamsbrown Wealth Consultants Wichita, Kansas $548M AUM 16.52% 1-Year Est. Return

Old National Bancorp Evansville, Indiana $5.07B AUM 22.07% 1-Year Est. Return

Rye Brook Capital Greenwich, Connecticut $154M AUM 17.54% 1-Year Est. Return

WT Wealth Management Scottsdale, Arizona $357M AUM 15.82% 1-Year Est. Return

Prime Capital Investment Advisors Overland Park, Kansas $10.2B AUM 17.74% 1-Year Est. Return

Fortis Group Advisors Westwood, New Jersey $623M AUM 25.42% 1-Year Est. Return

Fluent Financial Dallas, Texas $292M AUM 8.92% 1-Year Est. Return

Activest Wealth Management's PPH Position: Q3 2026 in Review

Activest Wealth Management held its VanEck Pharmaceutical ETF (PPH) position steady in Q3 2026 at 74 shares worth $8.1K. The position accounts for ﹤0.01% of the portfolio, ranked #618.

Activest Wealth Management first reported a position in PPH in Q4 2022 and has held it in 9 quarters since. The position peaked at $70.1K in Q4 2022. 70 funds tracked by Wall St. Rank hold PPH as of Q3 2026.

Activest Wealth Management held 74 shares of VanEck Pharmaceutical ETF worth $8.1K as of Q3 2026.
Activest Wealth Management left its VanEck Pharmaceutical ETF share count unchanged in Q3 2026.
VanEck Pharmaceutical ETF made up ﹤0.01% of Activest Wealth Management's portfolio in Q3 2026, its #618 holding.
Activest Wealth Management first reported a position in VanEck Pharmaceutical ETF in Q4 2022 and has held it in 9 quarters since.
Activest Wealth Management's VanEck Pharmaceutical ETF position peaked at $70.1K in Q4 2022.
70 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2026.

Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.